News
ACCD
8.70
+3.57%
0.30
Weekly Report: what happened at ACCD last week (0408-0412)?
Weekly Report · 3d ago
Accolade, Inc.: Report of proposed sale of securities
Press release · 6d ago
Weekly Report: what happened at ACCD last week (0401-0405)?
Weekly Report · 04/08 09:02
Accolade: Staying Bullish On Favorable Developments
Accolade, Inc. (NASDAQ:ACCD) shares are rated as a Buy. Accolade will announce quarterly results for the third quarter of fiscal 2024 on April 25. The company's latest Artificial Intelligence Excellence Award provides a validation of the potential AI-related tailwinds for the company. I am positive on the company's new partner additions and its latest developments.
Seeking Alpha · 04/05 10:34
Weekly Report: what happened at ACCD last week (0325-0329)?
Weekly Report · 04/01 09:02
Following a 23% decline over last year, recent gains may please Accolade, Inc. (NASDAQ:ACCD) institutional owners
51% of the business is held by the top 7 shareholders of Accolade, Inc. (NASDAQ:ACCD). The company has 77% of its shares held by institutions. The institutional investors own more than half of the company. In the last 12 months, accolade has lost 23% and is now valued at US$57m. We take a look at the company's ownership of shares in a list of the most common types of shareholders.  Accolade owns US$17m worth of stock in the company .
Simply Wall St · 03/29 11:41
Weekly Report: what happened at ACCD last week (0318-0322)?
Weekly Report · 03/25 09:02
Strength Seen in Paymentus (PAY): Can Its 7.8% Jump Turn into More Strength?
NASDAQ · 03/21 12:11
Press Release: Accolade Promotes Kelsi McDonald Harris to Chief People Officer
Accolade Promotes Kelsi McDonald Harris to Chief People Officer and Senior Vice President. McDonald Harris assumes new role on Executive Leadership Team to deliver an exceptional employee experience. She will oversee employee experience for Accolade's 2,400+ employees. She currently serves as Vice President of Strategy and Planning.
Dow Jones · 03/19 13:02
Weekly Report: what happened at ACCD last week (0311-0315)?
Weekly Report · 03/18 09:02
Weekly Report: what happened at ACCD last week (0304-0308)?
Weekly Report · 03/11 09:02
Weekly Report: what happened at ACCD last week (0226-0301)?
Weekly Report · 03/04 09:02
Balancing Potential and Prudence: A Hold Rating for Accolade’s Market Prospects and Financial Strategy
TipRanks · 02/27 10:59
Accolade Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)
7 analysts have expressed a variety of opinions on Accolade (NASDAQ:ACCD) over the past quarter. The company has an average price target of $15.29 with a 12-month average of $17.00. The average target is a 15.83% increase from the company's previous average.  Accolade Inc offers technology-enabled solutions that help people better understand the healthcare system.
Benzinga · 02/26 19:01
D.A. Davidson Remains a Hold on Accolade (ACCD)
TipRanks · 02/26 13:25
Accolade Initiated at Outperform by Leerink Partners
Dow Jones · 02/26 12:58
Accolade Price Target Announced at $16.00/Share by Leerink Partners
Dow Jones · 02/26 12:58
Leerink Partners Initiates Coverage On Accolade with Outperform Rating, Announces Price Target of $16
Benzinga · 02/26 12:48
Weekly Report: what happened at ACCD last week (0219-0223)?
Weekly Report · 02/26 09:02
Alabama’s Fertility Ruling Raises Challenges for Stocks of Fertility Benefits Providers
Alabama State Court’s ruling has sent shockwaves throughout the healthcare industry. Progyny and Accolade are among the companies affected by the ruling. The road ahead for companies connected to fertility treatments will be difficult. President Joe Biden has criticized the ruling as an attack on women's reproductive rights.
Investorplace · 02/23 19:14
More
Webull provides a variety of real-time ACCD stock news. You can receive the latest news about Accolade, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About ACCD
Accolade, Inc. provides personalized, technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. Its customers are primarily employers that deploy Accolade solutions in order to provide employees and their families with a single place to turn for their health, healthcare, and benefits needs. It also offers medical opinion services to commercial customers and virtual primary care and mental health support. Its platform, True Health Engine, combines open, cloud-based intelligent technology with multimodal support from a team of empathetic and knowledgeable Accolade Health Assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women’s health specialists, case management specialists, expert medical opinion providers, and virtual primary care physicians. Its offerings include Accolade Expert MD, Accolade Care, Plus and Connect and Accolade One.